News

A virus that causes childhood coughs and colds could help in the fight against primary liver cancer. Reovirus stimulates the body’s own immune system to kill off the cancerous cells, researchers from the University of Leeds discovered. In addition, Reovirus is able to kill off the hepatitis C virus – a common cause of primary…
The University has given the seal of approval to the proposed plans to create an international Centre for Engineering and Physical Sciences on the north eastern part of campus. The £96m project was approved by the Council, the University’s governing body, earlier this month. It is set to position the University as a world leading…
The MRC has come together with seven other research funders to create an interactive ‘map’ of the funding schemes available to biomedical researchers. The first of its kind focused on medical research, the ‘funding view’ takes the form of an interactive map, giving the user an easy way to navigate the UK biomedical research funding…
The vast majority of clinically approved protein kinase inhibitors target the ATP-binding pocket directly. Consequently, many inhibitors have broad selectivity profiles and most have significant off-target effects. Research at Leeds has shown how single domain antibodies can be used to characterize the regulatory mechanisms of kinases and provide a rational basis for structure-guided design of…
Novel models for anti-Toxoplasma gondii drug discovery Toxoplasma gondii, the most common parasitic infection of human brain and eye, persists across lifetimes, can progressively damage sight, and is currently incurable. New, curative medicines are needed urgently. Research at Leeds has developed novel models to facilitate drug development and used these models to envision, and then create, novel 4-(1H)-quinolone…